14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.331 $5.47 Wednesday, 24th Apr 2024 LGVN stock ended at $1.72. This is 5.49% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 8.93% from a day low at $1.68 to a day high of $1.83.
90 days $0.331 $5.47
52 weeks $0.331 $5.47

Historical Longeveron Inc. prices

Date Open High Low Close Volume
Apr 24, 2024 $1.83 $1.83 $1.68 $1.72 303 001
Apr 23, 2024 $1.91 $1.91 $1.76 $1.82 271 291
Apr 22, 2024 $1.98 $2.06 $1.81 $1.87 478 684
Apr 19, 2024 $1.92 $2.10 $1.90 $1.92 456 195
Apr 18, 2024 $2.09 $2.29 $1.93 $2.01 980 997
Apr 17, 2024 $2.53 $2.68 $1.93 $2.09 3 317 167
Apr 16, 2024 $2.97 $4.25 $2.60 $3.53 9 372 749
Apr 15, 2024 $2.39 $3.41 $2.15 $2.93 55 739 430
Apr 12, 2024 $2.18 $2.18 $1.62 $1.69 487 923
Apr 11, 2024 $2.17 $2.23 $2.01 $2.02 286 901
Apr 10, 2024 $2.01 $2.32 $2.00 $2.25 413 222
Apr 09, 2024 $2.01 $2.18 $1.91 $2.14 1 346 047
Apr 08, 2024 $3.74 $5.47 $2.03 $2.15 50 209 968
Apr 05, 2024 $2.06 $2.25 $1.84 $2.20 130 466
Apr 04, 2024 $2.48 $2.57 $2.02 $2.03 260 531
Apr 03, 2024 $2.79 $2.79 $2.40 $2.50 98 553
Apr 02, 2024 $2.87 $2.99 $2.70 $2.75 34 500
Apr 01, 2024 $3.16 $3.25 $2.82 $2.85 103 583
Mar 28, 2024 $3.64 $3.64 $3.20 $3.25 147 435
Mar 27, 2024 $2.92 $3.57 $2.92 $3.11 97 926
Mar 26, 2024 $0.395 $0.418 $0.331 $0.344 605 830
Mar 25, 2024 $0.400 $0.430 $0.380 $0.403 302 528
Mar 22, 2024 $0.404 $0.405 $0.370 $0.382 118 142
Mar 21, 2024 $0.368 $0.407 $0.360 $0.390 185 000
Mar 20, 2024 $0.424 $0.440 $0.350 $0.361 423 677
Click to get the best stock tips daily for free!

About Longeveron Inc.

Longeveron. Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, a... LGVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT